Literature DB >> 20350283

Diabetes, hyperglycemia and accelerated atherosclerosis: evidence supporting a role for endoplasmic reticulum (ER) stress signaling.

Cameron S McAlpine1, Anna J Bowes, Geoff H Werstuck.   

Abstract

Diabetes mellitus is associated with both micro- and macrovascular complications that can lead to significantly elevated incidence of retinopathy, nephropathy, neuropathy, myocardial infarction and stroke. The diabetic cardiovascular mortality rate exceeds 70% and individuals with diabetes are 2-3 times more likely to die from myocardial infarction and stroke than those with no history of diabetes even after controlling for other cardiovascular risk factors. Despite the profound clinical importance of vascular disease in patients with diabetes mellitus, our understanding of the molecular and cellular mechanisms by which diabetes promotes these vascular complications is incomplete. Endoplasmic reticulum (ER) stress and the unfolded protein response pathways have been previously associated with the development of several different diseases, including neurodegenerative disorders, cancer, and obesity. In addition, ER stress has been directly implicated in complications that are associated with diabetes, including pancreatic b cell dysfunction and insulin resistance. In this review we examine the potential role of endoplasmic reticulum stress in the initiation and progression of hyperglycemia-associated atherosclerosis.

Entities:  

Mesh:

Year:  2010        PMID: 20350283     DOI: 10.2174/187152910791292529

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  24 in total

1.  Endoplasmic reticulum stress in diabetes: New insights of clinical relevance.

Authors:  Muthuswamy Balasubramanyam; Raji Lenin; Finny Monickaraj
Journal:  Indian J Clin Biochem       Date:  2010-05-27

2.  Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells.

Authors:  Junyu Ning; Gang Xi; David R Clemmons
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

Review 3.  Insulin resistance, hyperglycemia, and atherosclerosis.

Authors:  Karin E Bornfeldt; Ira Tabas
Journal:  Cell Metab       Date:  2011-11-02       Impact factor: 27.287

4.  Increased monocyte-derived reactive oxygen species in type 2 diabetes: role of endoplasmic reticulum stress.

Authors:  Robert M Restaino; Shekhar H Deo; Alan R Parrish; Paul J Fadel; Jaume Padilla
Journal:  Exp Physiol       Date:  2017-01-10       Impact factor: 2.969

Review 5.  Diabetic neuropathy: cellular mechanisms as therapeutic targets.

Authors:  Andrea M Vincent; Brian C Callaghan; Andrea L Smith; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 6.  The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding.

Authors:  Sarah X Zhang; Jacey H Ma; Maulasri Bhatta; Steven J Fliesler; Joshua J Wang
Journal:  Prog Retin Eye Res       Date:  2014-12-18       Impact factor: 21.198

Review 7.  The role of endoplasmic reticulum stress in the progression of atherosclerosis.

Authors:  Ira Tabas
Journal:  Circ Res       Date:  2010-10-01       Impact factor: 17.367

8.  Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.

Authors:  Lauren K Walsh; Robert M Restaino; Martha Neuringer; Camila Manrique; Jaume Padilla
Journal:  Clin Sci (Lond)       Date:  2016-08-08       Impact factor: 6.124

9.  Modulation of angiogenesis by genetic manipulation of ATF4 in mouse model of oxygen-induced retinopathy [corrected].

Authors:  Xiaoqin Wang; Guibo Wang; Mansi Kunte; Vishal Shinde; Marina Gorbatyuk
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-03       Impact factor: 4.799

10.  The pivotal role of high glucose-induced overexpression of PKCβ in the appearance of glucagon-like peptide-1 resistance in endothelial cells.

Authors:  Gemma Pujadas; Valeria De Nigris; Lucia La Sala; Roberto Testa; Stefano Genovese; Antonio Ceriello
Journal:  Endocrine       Date:  2015-11-19       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.